Indeed, perturbations in Glut1 levels have been implicated in conditions as diverse as diabetes, cancer, retinitis pigmentosa (RP), and Alzheimer's disease (AD). Here, SLC2A1 is linked to early-onset autosomal dominant Alzheimer disease.